Di Nuzzo Private Wealth, Inc. United Therapeutics Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 12 shares of UTHR stock, worth $3,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$3,699
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
724Shares Held
40.4MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$851 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$678 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$644 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...